Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake
Pain Research and Management · 2025
DOI: 10.1155/prm/5656675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Research and Management, 2025. Verfasst von Zihan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China. Hauptthemen laut MEDLINE: Receptors, Opioid, kappa, Receptors, Opioid, mu, Chronic Pain, Tetrahydronaphthalenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Dezocine is a leading analgesic in China used for relieving moderate to severe pain. Previous studies have characterized its pharmacological properties, demonstrating its role as a partial agonist at both the κ‐opioid receptor (KOR) and the μ‐opioid receptor (MOR), thereby producing potent antinociceptive effects in acute pain models. However, its efficacy and mechanisms in chronic pain management remained unclear.
Methods
Chronic pain models, including chronic neuropathic pain and cancer pain, were employed using chronic constriction injury (CCI) of the sciatic nerve and bone cancer pain (BCP) methodologies, respectively. The assessment of the mechanical allodynia was conducted using a von Frey filament.
Results
Dezocine, administered via the intraperitoneal route, alleviated both neuropathic pain and cancer pain in a dose‐dependent manner, with ED 50 of 1.3 mg/kg and 1.6 mg/kg, respectively. In the CCI model, the analgesic effect of dezocine was significantly inhibited by pretreating with KOR antagonist nor‐BNI, MOR antagonist β‐FNA, α2‐adrenoceptor antagonist yohimbine, and 5‐HT2A receptor antagonist altanserin. In the BCP model, dezocine‐induced analgesia was markedly suppressed by nor‐BNI, β‐FNA, and yohimbine but not altanserin.
Conclusion
These results suggest that, in neuropathic pain, the analgesic effects of dezocine are mediated through KOR and MOR activation, together with norepinephrine reuptake inhibition (NRI) and serotonin reuptake inhibition. In contrast, in cancer pain, KOR and MOR activation and NRI are involved in mediating the analgesic effect of dezocine. This study, along with previous data, enhances our understanding of the potential clinical utility of dezocine and elucidates its mechanisms of action in chronic pain management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
ORCID-Profile: Jing-Gen Liu, Yu-Jun Wang
Förderung
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Liu, Z., Liu, A., Chen, J., Chai, J. R., Liu, P., Ye, R. F., Liu, J. G., & Wang, Y. J. (2025). Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake. Pain Research and Management. https://doi.org/10.1155/prm/5656675
Vancouver
Liu Z, Liu A, Chen J, Chai JR, Liu P, Ye RF, et al. Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake. Pain Research and Management. 2025. doi:10.1155/prm/5656675
BibTeX
@article{Liu2025,
author = {Liu, Zihan and Liu, Anan and Chen, Jing and Chai, Jing-Rui and Liu, Panwen and Ye, Ru-Feng and Liu, Jing-Gen and Wang, Yu-Jun},
title = {Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ‐ and μ‐Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake},
journal = {Pain Research and Management},
year = {2025},
doi = {10.1155/prm/5656675}
}
EUVIMED